CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the country’s supply of bird flu vaccines. The grant comes from the ...

As part of the agreement, GSK, Sanofi, and CSL will produce extra bulk vaccine components tailored to the circulating strains of avian influenza. Also Read: Medicare Drug Price Negotiation Program ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50. The company’s shares closed yesterday at p1,497. ...

Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £18.00. The company’s shares closed yesterday at p1,497. ...

Today, the Portfolio Committee on Trade and Industry was briefed by the DTI on a programme to revitalise zombie industrial parks, created by the former Apartheid government in outlying rural areas.

GSK’s Vi­iV Health­care has sus­pend­ed de­vel­op­ment of a Phase 2-stage HIV an­tivi­ral named VH3739937, a GSK spokesper­son con­firmed to End­points News on Tues­day.

During a media briefing yesterday, Vodafone Qatar officials introduced the plans that included ‘exclusive unlimited social media data’, ‘unlimited local minutes’, ‘Multi-SIM’, ‘mute ...

We recently made a list of the 10 Best Global Stocks To Buy Now. In this piece, we will look at where GSK plc (NYSE:GSK) ranks among the top ten global stocks to buy. With the third quarter of ...

The world’s first RSV vaccines were approved by the FDA last year in the forms of GSK’s Arexvy and Pfizer’s Abrysvo. Both are designed to help prevent this common cold virus that can in the ...

GSK Plc CEO Emma Walmsley doesn’t want the company’s employees spending any time thinking about the ongoing litigation over its old heartburn drug Zantac, an issue that has weighed on the ...

GSK recently announced the discontinuation of its herpes simplex virus (HSV) therapeutic vaccine candidate, GSK3943104, following the failure of a Phase I/II clinical trial to meet its primary ...

HSV remains a highly prevalent infection worldwide, with millions affected. Credit: Lightspring via Shutterstock. GSK recently announced the discontinuation of its herpes simplex virus (HSV) ...